Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice
Table 3
Serum IL-9 levels in patients with concomitant risk factors for hypertension.
Factors
Number with factor
Number without factor
Serum IL-9 levels
Type III of square
value
value
With factor
Without factor
Hypertension
80
50
33.2 (24.3, 40.9)
24.1 (18.3, 27.9)
372316
178
<0.001
Hyperlipidemia
35
95
28.2 (21.3, 35.9)
27.9 (21.1, 35.2)
28
0.01
0.952
T2DM
4
126
27.7 (20.3, 34.7)
28.4 (21.6, 36.1)
122
1.09
0.468
Male
85
45
25.5 (21.4, 33.8)
30.7 (25.4, 38.7)
19523
104
0.008
Elderly
54
76
28.5 (24.9, 34.2)
28.9 (25.1, 35.1)
4523
29
0.774
Smoking
49
81
31.5 (25.4, 35.5)
27.5 (23.4, 31.6)
5263
54
0.002
Drinking
36
94
24.1 (20.7, 34.1)
31.7 (21.9, 39.9)
415321
264
<0.001
Obesity
90
40
29.9 (24.1, 36.1)
26.9 (23.3, 33.1)
872
32
0.028
Family history
57
73
28.7 (23.5, 35.1)
27.8 (22.9, 34.7)
6732
136
0.198
Hyperlipidemia: total plasma mmol/L or mmol/L; T2DM: according to the results of oral glucose tolerance test; elderly: years; smoking: current or within the last 6 months; drinking: more than 150 mL/day, current or within the last 6 months; obesity: kg/m2; family history: at least one person of the parents suffering hypertension.
